Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shigeki Shimasaki"'
Autor:
Mari Wataya-Kaneda, Hiroshi Nagai, Yuuki Ohno, Hiroo Yokozeki, Yasuyuki Fujita, Hironori Niizeki, Kazue Yoshida, Masaaki Ogai, Yuichi Yoshida, Akihiko Asahina, Kazuyoshi Fukai, Chiharu Tateishi, Izumi Hamada, Tatsuro Takahata, Kenji Shimizu, Shigeki Shimasaki, Hiroyuki Murota
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 4, Pp 635-650 (2020)
Abstract Introduction Our previous clinical studies have demonstrated the short-term efficacy and safety of the sirolimus gel for patients with tuberous sclerosis complex (TSC). However, long-term clinical evidence is lacking. Our objective was to as
Externí odkaz:
https://doaj.org/article/71187a866eb04dbdad37e301feef95c2
Autor:
Hironori Niizeki, Chiharu Tateishi, Kazuyoshi Fukai, Shigeki Shimasaki, Yasuyuki Fujita, Izumi Hamada, Tatsuro Takahata, Akihiko Asahina, Yuuki Ohno, Hiroyuki Murota, Hiroo Yokozeki, Masaaki Ogai, Kenji Shimizu, Mari Wataya-Kaneda, Yuichi Yoshida, Kazue Yoshida, Hiroshi Nagai
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 4, Pp 635-650 (2020)
Dermatology and Therapy
Dermatology and Therapy
Introduction Our previous clinical studies have demonstrated the short-term efficacy and safety of the sirolimus gel for patients with tuberous sclerosis complex (TSC). However, long-term clinical evidence is lacking. Our objective was to assess the
Autor:
Susumu Kobayashi, Tadayuki Hiroki, Naotaka Usui, Yushi Inoue, Kenji Shimizu, Shigeki Shimasaki
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics
To compare and evaluate the bioavailability for intravenous fosphenytoin sodium with that of intravenous phenytoin sodium in Japanese subjects. In study 1, healthy Japanese male volunteers received a 30-min infusion of 375 mg fosphenytoin sodium or a
Publikováno v:
European Journal of Clinical Pharmacology
Purpose We performed a population pharmacokinetic analysis of phenytoin after intravenous administration of fosphenytoin sodium in healthy, neurosurgical, and epileptic subjects, including pediatric patients, and determined the optimal dose and infus
Autor:
Wataya-Kaneda, Mari1 (AUTHOR) mkaneda@derma.med.osaka-u.ac.jp, Nagai, Hiroshi2 (AUTHOR), Ohno, Yuuki3 (AUTHOR), Yokozeki, Hiroo4 (AUTHOR), Fujita, Yasuyuki5 (AUTHOR), Niizeki, Hironori6 (AUTHOR), Yoshida, Kazue6 (AUTHOR), Ogai, Masaaki7 (AUTHOR), Yoshida, Yuichi8 (AUTHOR), Asahina, Akihiko9 (AUTHOR), Fukai, Kazuyoshi10,11 (AUTHOR), Tateishi, Chiharu10 (AUTHOR), Hamada, Izumi12 (AUTHOR), Takahata, Tatsuro12 (AUTHOR), Shimizu, Kenji12 (AUTHOR), Shimasaki, Shigeki12 (AUTHOR), Murota, Hiroyuki13 (AUTHOR)
Publikováno v:
Dermatology & Therapy. Aug2020, Vol. 10 Issue 4, p635-650. 16p.
Publikováno v:
European Journal of Clinical Pharmacology; Mar2013, Vol. 69 Issue 3, p489-497, 9p, 1 Diagram, 3 Charts, 5 Graphs
Japan’s Nobelpharma Selects Medidata as Technology Partner for New Clinical Study on Sleep Disorders
Autor:
Medidata
Publikováno v:
Business Wire (English). 11/01/2016.